密迪斯肌控股有限公司（08307）于2026年3月2日发布截至2026年2月28日的股份变动月报表。报告显示，公司法定股本及已发行股份在本月并无变化，股本保持稳定。
根据公告资料，公司法定/注册股本保持在10,000,000港元，对应1,000,000,000股，面值每股0.01港元；本月底已发行股份总数为396,736,000股，与上月底一致，当月无新增发行、回购或注销活动。
公告同时披露，公司于2024年9月27日采纳的购股权计划可行使股份数量为39,673,600股。当月并无新增股份因行使期权而发行，也无库藏股份变动。
公司在公告中确认，截至本月末已符合适用的公众持股量要求，并遵守香港联合交易所有限公司《上市规则》及其他相关法律法规。公告由执行董事兼公司秘书冼翠碧签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.